- Home
- RNAZ vs AMST Comparison
RNAZ vs AMST Comparison
Compare RNAZ & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAZ | AMST |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 9.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RNAZ | AMST |
|---|---|---|
| Price | $9.39 | $1.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $280.00 | N/A |
| AVG Volume (30 Days) | ★ 135.8K | 36.4K |
| Earning Date | 11-14-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $193,505.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 68.56 |
| 52 Week Low | $6.08 | $1.76 |
| 52 Week High | $399.00 | $4.78 |
Technical Indicators
Market Signals| Indicator | RNAZ | AMST |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 44.11 |
| Support Level | $8.35 | $1.76 |
| Resistance Level | $10.00 | $2.30 |
| Average True Range (ATR) | 0.98 | 0.14 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 13.17 | 31.48 |
Price Performance
Historical ComparisonAbout RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.